Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD)

NCT00910897 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

205

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Velcade-Dexamethasone
DRUG: Velcade-Thalidomide-Dexamethasone

Sponsor

Intergroupe Francophone du Myelome